Iimpawu zoMsebenzi
Umda wokufumanisa: 0.5 mg / L;
Uluhlu lomgca: 0.5～200 mg / L;
I-coefficient yokulungelelanisa yomgca R ≥ 0.990;
Ukuchaneka: ngaphakathi kwe-batch CV ngu ≤ 15%;phakathi kweebhetshi iCV yi ≤ 20%;
Ukuchaneka: ukutenxa okunxulumene neziphumo zomlinganiselo akusayi kudlula ±I-15% xa i-calibrator yokuchaneka elungiselelwe ngumgangatho wesizwe we-CRP okanye i-1.0mg/Land 10.0mg/L i-standard standardized accuracy calibrator ivavanywa.
1. Gcina i-detector buffer ku-2～30℃.Isithinteli sizinzile ukuya kwiinyanga ezili-18.
2. Gcina i-Aehealth Ferritin Rapid Quantitative test cassette kwi-2～30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.
3. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.
I-C - iprotheni esebenzayo (CRP) idityaniswe sisibindi ekuphenduleni i-interleukin-6 kwaye iyaziwa njengenye ye-classical acute-phase reactants kunye ne-marker of inflammation.Izinga le-serum ye-CRP inokunyuka ukusuka kwinqanaba eliqhelekileyo le-<5 mg / L ukuya kwi-500 mg / L ngexesha lomzimba jikelele, impendulo engabonakaliyo kwizinto ezithathelwanayo kunye nezinye iziganeko ezivuthayo.i-high-sensitivity CRP (hsCRP) iphinda ibonakale njengeyona nto inamandla kunye neyona nto izimeleyo yomngcipheko we-atherosclerosis kunye nezifo ze-cardiovascular (CVD) .Kubantu ukuxilongwa kwesifo sokuvuvukala kunye ne-CVD assessment cutoffs kuye kwacetyiswa ngolu hlobo lulandelayo:
| Ugxininiso | Ireferensi yeklinikhi |
| <1.0 mg/L | Umngcipheko ophantsi we-CVD (Akukho Simo sokudumba) |
| 1.0〜3.0 mg/L | Umngcipheko we-CVD ophakathi (Akukho Simo sokudumba) |
| >3.0 mg/L | Umngcipheko ophezulu we-CVD (Akukho Simo sokudumba) |
| >10 mg/L | Kusenokubakho olunye usulelo (usulelo lwebhaktiriya okanye usulelo lwentsholongwane) |
| 10 ~ 20 mg/L | Ngokuqhelekileyo ibonisa usulelo lwentsholongwane okanye usulelo oluncinci lwebhaktheriya |
| 20~50 mg/L | Ngokuqhelekileyo ibonisa usulelo oluphakathi lwebhaktheriya |
| >50 mg/L | Ngokuqhelekileyo ibonisa usulelo olubi lwebhaktheriya |